| |
| |
|
| Insider
Information: |
Sun Anthony Y |
| Relationship: |
President & CEO, Direc... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,218,828 |
|
|
Indirect Shares
|
3,556,120 |
|
|
| Direct
Value |
$18,671 |
|
|
|
Indirect Value
|
$85,797 |
|
|
| Total
Shares |
4,774,948 |
|
|
| Total
Value |
$104,468 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aravive Inc |
ARAV |
Director |
2017-12-20 |
23,880 |
2015-01-27 |
2,139,568 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
19,359 |
2018-07-24 |
0 |
Premium* |
|
|
Zentalis Pharmaceuticals, Llc |
ZNTL |
President & CEO, Direc... |
2022-04-05 |
1,175,589 |
2022-04-05 |
1,416,552 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-04-05 |
4 |
AS |
$51.34 |
$539,474 |
D/D |
(10,471) |
1,175,589 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-04-04 |
4 |
AS |
$48.50 |
$507,844 |
D/D |
(10,471) |
1,186,060 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-03-02 |
4 |
AS |
$50.11 |
$525,265 |
D/D |
(10,471) |
1,196,531 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-03-01 |
4 |
AS |
$49.74 |
$521,384 |
D/D |
(10,471) |
1,207,002 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-02-14 |
4 |
AS |
$50.16 |
$237,733 |
D/D |
(4,733) |
1,217,473 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,431 |
1,222,206 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-02-02 |
4 |
AS |
$57.87 |
$606,966 |
D/D |
(10,471) |
1,171,775 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-02-01 |
4 |
AS |
$56.81 |
$602,926 |
D/D |
(10,471) |
1,182,246 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-01-04 |
4 |
AS |
$77.71 |
$823,870 |
D/D |
(10,471) |
1,192,717 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2022-01-03 |
4 |
AS |
$78.26 |
$838,438 |
D/D |
(10,471) |
1,203,188 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
1,213,659 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-11-26 |
4/A |
GD |
$0.00 |
$0 |
I/I |
125,000 |
103,650 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-11-02 |
4 |
AS |
$79.40 |
$842,602 |
D/D |
(10,471) |
1,249,601 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-11-01 |
4 |
AS |
$80.72 |
$852,772 |
D/D |
(10,471) |
1,260,072 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-10-04 |
4 |
AS |
$65.95 |
$1,777,707 |
D/D |
(26,799) |
1,270,543 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-09-01 |
4 |
AS |
$67.09 |
$1,808,716 |
D/D |
(26,794) |
1,297,342 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-08-03 |
4 |
AS |
$50.01 |
$393,090 |
D/D |
(7,779) |
1,324,136 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-08-02 |
4 |
AS |
$50.01 |
$970,247 |
D/D |
(19,015) |
1,331,915 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-07-07 |
4 |
AS |
$46.08 |
$839,114 |
D/D |
(17,804) |
1,350,930 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-07-06 |
4 |
AS |
$46.78 |
$1,174,488 |
D/D |
(25,045) |
1,368,734 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-07-01 |
4 |
AS |
$50.17 |
$1,372,235 |
D/D |
(26,794) |
1,393,779 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-06-01 |
4 |
AS |
$53.95 |
$1,447,679 |
D/D |
(26,794) |
1,420,573 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-05-03 |
4 |
AS |
$57.04 |
$1,589,506 |
D/D |
(26,794) |
1,447,367 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-04-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
228,650 |
228,650 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
President & CEO |
• • – |
2021-04-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
228,650 |
1,474,161 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
